Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.61 |
| ▸ | AOC2 | O75106 | 3/20 | 0.59 |
| ▸ | CES1 | P23141 | 2/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CNR2 | P34972 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28363647 | 0.98 | MEN1 (0.63) | MEN1KMT2AHDAC8HDAC6CYP1A2 | |
| Methyl Alcohol SCHEMBL11870034 | 0.96 | MEN1 (0.61) | MEN1KMT2AHDAC8HDAC6CYP1A2 | |
| SCHEMBL28285072 | 0.92 | MEN1 (0.57) | MEN1KMT2AHDAC8HDAC6CYP1A2 | |
| SCHEMBL2513961 | 0.89 | ALDH1A1 (0.68) | MEN1KMT2AHDAC8HDAC6CYP1A2 | |
| SCHEMBL11796135 | 0.88 | AOC2 (0.66) | MEN1KMT2AHDAC8HDAC6CYP1A2 | |
| SCHEMBL6869213 | 0.88 | KMT2A (0.66) | MEN1KMT2AHDAC8HDAC6AOC2 | |
| SCHEMBL7194491 | 0.84 | AOC2 (0.67) | MEN1KMT2AHDAC8HDAC6CYP1A2 | |
| SCHEMBL28114492 | 0.84 | MEN1 (0.49) | MEN1KMT2AHDAC8HDAC6CYP1A2 | |
| SCHEMBL1732806 | 0.83 | ALDH1A1 (0.63) | HDAC6CYP1A2ALDH1A1LMNA | |
| SCHEMBL27499470 | 0.83 | MEN1 (0.61) | MEN1KMT2AHDAC8HDAC6EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1082 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080895-A | Polyglycolic acid composition and preparation method thereof, biodegradable polyester material and application thereof, and PGA temporary plugging ball and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-119836205-A | Perovskite solar cell based on multifunctional additive and preparation method thereof | 东方电气长三角(杭州)创新研究院有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119661782-A | PVDF material with dispersed anti-gel function for positive electrode slurry and preparation method thereof | 郑州大学 | 2025-03-21 | — | — | CN | claimed |
| CN-119372909-A | Unidirectional moisture-conducting biodegradable non-woven fabric and preparation method thereof | 福州大学 | 2025-01-28 | — | — | CN | claimed |
| CN-117683336-B | Bamboo charcoal biodegradable conductive composite material and preparation method thereof | 国际竹藤中心 | 2024-04-23 | — | — | CN | claimed |
| CN-117683336-A | Bamboo charcoal biodegradable conductive composite material and preparation method thereof | 国际竹藤中心 | 2024-03-12 | — | — | CN | claimed |
| CN-113896689-B | Preparation method of oxaziclomefone | 北京颖泰嘉和生物科技股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-114057661-B | Preparation method of oxaziclomefone | 浙江中山化工集团股份有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-113620778-B | Method for preparing allyl alcohol compound by reduction of propargyl alcohol compound | 万华化学集团股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| US-11398630-B2 | Method of generating energy from a hydrazide containing anode fuel, and fuel cell | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-07-26 | — | — | US | claimed |
| WO-2009150834-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | 住友ベークライト株式会社 (JP) | 2009-12-17 | — | — | WO | claimed |
| US-20090306291-A1 | SUGAR CHAIN-CAPTURING SUBSTANCE AND USE THEREOF | SUMITOMO BAKELITE CO., LTD. (JP) | 2009-12-10 | — | — | US | claimed |
| CN-101501492-A | Sugar chain-capturing substance and use thereof | SUMITOMO BAKELITE CO (JP) | 2009-08-05 | — | — | CN | claimed |
| EP-2056106-A1 | SUGAR CHAIN-CAPTURING SUBSTANCE AND USE THEREOF | Sumitomo Bakelite Company, Ltd. (JP) | 2009-05-06 | — | — | EP | claimed |
| US-7387771-B1 | dissolving in carrier liquid; drug linked to a protein-binding molecule via a spacer which is cleaved hydrolytically or enzymatically in the body of a subject in a pH-dependent manner; tissue targeted delivery; Doxorubicin-phenylacetylhydrazone spacer-maleimide | KTB TUMORFORSCHUNGS GMBH (DE) | 2008-06-17 | — | — | US | claimed |
| US-20060233707-A1 | Process for producing an injectable medicament preparation | KTB TUMORFORSCHUNGS GMBH (DE) | 2006-10-19 | — | — | US | claimed |
| EP-1465613-A2 | COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2004-10-13 | — | — | EP | claimed |
| EP-1135363-B1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | GREAT LAKES CHEMICAL EUROP (CH) | 2003-09-24 | — | — | EP | claimed |
| WO-2003057205-A2 | COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2003-07-17 | — | — | WO | claimed |
| US-6444848-B1 | REACTING HYDRAZINE WITH ACID CHLORIDE | GREAT LAKES CHEMICAL (EUROPE) GMBH (DE) | 2002-09-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060233707-A1 | Process for producing an injectable medicament preparation | MMP1, MMP2, DNPEP | MEN1 1234/4885KMT2A 4845/4885HDAC8 4266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.